A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis

References

• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–31.
   PubMed Web of Science ®Google Scholar
• Farrell GC, Larter CZ. Non-alcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S1–12.
   Google Scholar
• Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, Nonalcoholic fatty fiver disease a feature of the metabolic syndrome. Diabetes 2001;50:1844–50.
   PubMed Web of Science ®Google Scholar
• Serfaty L, Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab 2008;34:634–7.
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med 2009;87:679–95.
   PubMed Web of Science ®Google Scholar
• Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 2007;47:142–56.
   PubMed Web of Science ®Google Scholar
• Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829–38.
   PubMed Web of Science ®Google Scholar
• Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in non-alcoholic fatty liver. Hepatology 2000;32:3–10.
   PubMed Web of Science ®Google Scholar
• Matteoni CA, Younossi ZM, Gramich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413–9.
   PubMed Web of Science ®Google Scholar
• Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 2006;91:1081–6.
   PubMed Web of Science ®Google Scholar
• Larter CZ, Yeh MM. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 2008;23:1635–48.
   PubMed Web of Science ®Google Scholar
• Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with suppression of SCD-1. J Lipid Res 2006;47:2280–90.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Otabe S, Ueno T, Hirota N, Yuan X, Fukutani T, Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis. Metabolism 2007;56:470–5.
   PubMedGoogle Scholar
• Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB 2005;19:136–8.
   PubMed Web of Science ®Google Scholar
• Deng Q, She H, Cheng JH, French SW, Koop DR, Xiong S, Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 2005;42:905–14.
   PubMed Web of Science ®Google Scholar
• Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004;40:47–51.
   PubMed Web of Science ®Google Scholar
• Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res 2008;49:1068–76.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087–92.
   PubMed Web of Science ®Google Scholar
• Davalli AM, Ogawa Y, Scaglia L, Wu YJ, Hollister J, Bonner-Weir S, Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 1995;44:104–11.
   PubMedGoogle Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467–74.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Koteish A, Diehl AM. Animal model of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16(5):679–90.
   PubMedGoogle Scholar
• Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 2009;9:299–314.
   PubMedGoogle Scholar
• Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106:165–9.
   PubMed Web of Science ®Google Scholar
• Virkamäki A, Ueki K, Kahn CR. Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999;103:931–3.
   PubMed Web of Science ®Google Scholar
• Akiba Y, Takahashi K, Kimura M, Hirama SI, Matsumoto T. The influence of environmental temperature, thyroid status and a synthetic oestrogen on the induction of fatty livers in chicks. Br Poult Sci 1983;24:71–80.
   PubMed Web of Science ®Google Scholar
• Rivkees SA, Mattison DR. Ending propylthiouracil-induced liver failure in children. N Engl J Med 2009;360:1574–5.
   PubMed Web of Science ®Google Scholar
• Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10:1018–23.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7.
   PubMed Web of Science ®Google Scholar
• Serino M, Menghini R, Fiorentino L, Amoruso R, Mauriello A, Lauro D, Mice heterozygous for tumor necrosis factor-α converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes 2007;56:2541–6.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772–83.
   PubMed Web of Science ®Google Scholar